Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARBOPLATIN vs CARBOPROST TROMETHAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CARBOPLATIN vs CARBOPROST TROMETHAMINE: Safety Overview

Metric CARBOPLATIN CARBOPROST TROMETHAMINE
Total FAERS Reports 84,088 653
Deaths Reported 12,544 2
Death Rate 14.9% 0.3%
Hospitalizations 35,869 54
Average Patient Age 58.4 yrs 30.3 yrs
% Female Patients 58.7% 99.6%
FDA Approval Date Apr 24, 2007 Approved Prior to Jan 1, 1982
Manufacturer Ingenus Pharmaceuticals, LLC Dr. Reddys Laboratories Inc.
Route INTRAVENOUS INTRAMUSCULAR
Marketing Status Discontinued Prescription